Director, Single-Cell Genomics Program, Center for Immunology and Inflammatory Diseases. Assistant Professor of Medicine, Harvard Medical School. Associate Scientist, Broad Institute of MIT and Harvard.
Dr. Steve Blum is a medical oncology fellow who is interested in using systems immunology approaches to understand the relationship between the anti-tumor effects and toxicities that result from cancer immunotherapies.
Michelle is physician-scientist studying how epithelial and other stromal cells interface with infiltrating immune cells to preserve tissue function in organ-specific autoimmunity, using human thyroid autoimmunity as a model system.
Rachelly is a computational postdoc in the lab interested in studying autoimmune and infectious diseases by integrating multi-omic measurements at the single cell level. Specifically, Rachelly is working on studying immune-epithelial cell interactions in the thyroid gland in autoimmune and healthy patients. In addition, Rachelly leads the computational efforts to create a pan-disease blood cell atlas as part of the global Immune Cell Atlas project. This project will include a total of 15M cells in 30 different diseases and will serve as a comprehensive references for future PBMC studies.
Dr. Adrien Antoinette is a computational biologist utilizing single cell -omics approaches to study immune-related diseases. He is specially interested in systems approaches to understand cross-tissue and cross-disease pathological phenotypes.
Dr. Dan Zlotoff is a heart failure fellow and is interested in immune responses in the heart. He is currently studying the underlying mechanisms of immune checkpoint inhibitor-associated myocarditis.
Dr. Leyre Zubiri is a medical oncologist specializing in patients receiving immunotherapy and suffering from secondary adverse events on the Severe Immunotherapy Complications service at MGH. Her PhD was focused on the liquid biopsy as a way to identify soluble tumor biomarkers in patients with malignant melanoma. She is actively engaged in the clinical and translational research effort in these patients to develop biomarkers to diagnose these toxicities earlier, allowing for appropriate management.
Elizabeth is an MD-PhD student interested in women’s health. She is working with Dr. Villani and Dr. Douglas Kwon to define the single-cell landscape of the lower female reproductive tract.
Neal is a computational biologist utilizing single-cell -omics approaches to study the immune system in healthy and pathological states. Specifically, he is interested in understanding T cell mediated responses and how we can utilize TCR repertoire data to better understand T cell biology.
Swetha is a computational biologist who develops and utilizes computational approaches to analyze single-cell -omics datasets. Specifically, she focuses on the ICI-related myocarditis efforts and other collaborative projects.
Juliet is a research technician based in the Kwon Lab who is currently working to optimize processing of female reproductive tract samples for single-cell sequencing.
Aonkon is interested in developing solutions for single-cell genomics that leverage a comprehensive knowledge of biology, mathematics and computer science. Currently engaged in using single-cell multi-omics to derive cellular biomarkers and gene signatures for immunotherapy response, immune-related adverse events, and developing in-silico strategies for finding new CAR T therapies for oncology.
Hoang is interested in the intersection of genomics, transcriptomics, autoimmune diseases, especially in the context of non-coding regions in the human genome
Wamia is a recent graduate from University of Virginia.
Instructor in Medicine, Brigham and Women’s Hospital
Member of the Faculty of Medicine, Harvard Medical School. Gary is a Rheumatologist Clinician Scientist with an interest in applying genomics and systems biology approaches to immune-mediated rheumatic diseases with a particular interest in Giant Cell Arteritis.